MUMBAI, India, May 1 -- Intellectual Property India has published a patent application (202611025967 A) filed by Noida Institute Of Engineering & Technology, Greater Noida, Uttar Pradesh, on March 5, for 'a method for formulation and evaluation of antidiabetic drug loaded transdermal patches for diabetes treatment.'
Inventor(s) include Dr Monika; Dr Rupa Mazumder; Km. Preeti Jaiswal; Dr Swarupanjali Padhi; and Dr Chandana Majee.
The application for the patent was published on May 1, under issue no. 18/2026.
According to the abstract released by the Intellectual Property India: "Disclosed herein is a method (100) for formulation and evaluation of antidiabetic drug loaded transdermal patches for diabetes treatment comprises systematic stages beginning with pre-formulation testing (102). Standard calibration curves of the antidiabetic drug are prepared (104) in phosphate buffer and methanol using ultraviolet spectrophotometry to enable accurate drug quantification. Suitable polymers, copolymers, and plasticizers are selected (106) based on literature review, followed by optimization of the formulation (108) using a central composite design to achieve sustained drug release and enhanced skin permeation. The transdermal patches are formulated (110) by solvent casting and evaporation under controlled conditions and subsequently evaluated (112) for physicochemical and mechanical properties. In vitro diffusion testing is conducted (114) using a modified Franz diffusion apparatus, and release data are analyzed (116) using kinetic models to determine release mechanisms. Finally, in vivo pharmacological evaluation (118) in diabetic experimental models confirms antidiabetic efficacy through biochemical assessments."
Disclaimer: Curated by HT Syndication.
